Friday, August 08, 2008 Free Registration Log-in to View Profiles
Empire Relations Group is a Premier Investor Relations Organization representing publicly-traded companies in their communications programs with existing shareholders and potential investors.
investments
OTCBB
OTCBB
Pressroom 
 
 Archived
 
 Non-Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
 
 Public Companies
 Consumer
 Energy, Environment & Natural Resources
 Financials
 Healthcare/BioTech
 Industrials
 IT & Computers
 Materials
 Telecommunications
 Utilities
Search


Non-Public Companies : Healthcare/BioTech


New Study Analyzes Medical Science Liaisons' Programs, Finds Function's Strategic Influence Increasing

Apr 9, 2008 - 6:36:01 AM

News Source MARKET WIRE

Email this article
 Printer friendly page
RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- 04/09/08 -- Medical science liaisons'strategic importance is on the rise, according to a new report frompharmaceutical business intelligence leader Cutting Edge Information.

"The Changing MSL Role: Proving Value Through Performance Measurement,"explores the strategic direction of medical science liaisons (MSL) programswithin top pharmaceutical companies. It emphasizes MSLs' elevatedstrategic importance and their changing responsibilities in today'spharmaceutical landscape. Broken down by company size, the reportbenchmarks MSL team structures, spending and staffing resources, educationlevels and field force strategies.

The 203-page report was developed from survey and interview data for 30pharmaceutical and biotechnology companies. Its findings enable companiesto improve their thought leader management by maximizing their MSLs' value,scientific knowledge and relationship-building skills. Download acomplimentary report summary here:http://cuttingedgeinfo.com/mslperformance/PH115_Download.asp#body

This study covers these key aspects of MSL programs:

--  Structure, Budgets and Staffing: This section details companies'    structuring and alignment strategies, investment levels, and headcounts.--  MSL Qualifications and Performance Measurement: This section explores    the increasing educational and clinical experience required for MSL    candidates.  It includes compensation data.  It also examines ways in which    companies gauge MSL effectiveness and contributions to company goals.--  Field Force Strategies and Communication:  This section outlines MSL    activities and responsibilities.  It also examines the connections between    sales forces and MSLs in the new compliance environment and provides    recommendations for integrated communications between those groups.    

The report contains 500+ metrics, including the following:

--  Number of thought leader relationships by company size--  Degrees required by MSLs working with PCP thought leaders--  Breakdowns of thought leader relationships by company size and    provider category--  Ratio of MSLs to sales reps    

"Regulatory pressures and diminishing pipelines are affectingpharmaceutical functions across the industry, but the impact is especiallysignificant for MSLs," says Elio Evangelista, Research Team Leader atCutting Edge Information. "Companies now rely even more heavily on medicaleducation and thought leader management. MSLs are moving into morestrategic roles. Companies that recognize and adapt to MSLs' increasedimportance as knowledge providers position themselves for success."

Report Website: www.MSLPerformance.com

CONTACT INFORMATION:
Elio Evangelista:
Email Contact
919-433-0214.



Top of Page | Main News Index | EmpireRelations.com Home Page EmpireRelations.com Selected Clients News

Come see our services. Copr. © 2005 Empire Relations Group, Inc.

Healthcare/BioTech
Latest Headlines
Eye Surprise: School Screenings Miss 95% of Kids' Vision Problems, Say Experts
American Diabetes Association Applauds U.S. Senate for Introducing Bill to Protect the Rights of Americans With Disabilities
Bilcare GCS Opens New Global U.S. Headquarters
Fully-Dedicated Competitive Intelligence Groups on the Rise, Cutting Edge Information Study Finds
OctoPlus Postpones Publication of 2008 Half-Year Results Until Publication of 2007 Annual Report
Regulatory approval of Basilea's Toctino(R) (alitretinoin) recommended by concerned EU Member States
Primera Bioscience Research Inc. Press Release
Volunteers Needed for Emphysema Study
Cutting Edge Information's Research on Monoclonal Antibodies Drives Forecasts for the Oncology Market
Dallas Psychiatrist's Paranormal Abilities to Be Tested by Noted Debunker James Randi